Literature DB >> 15650283

Fascioliasis: an exceptional cause of acute pancreatitis.

Miguel Echenique-Elizondo1, José Amondarain, Carlos Lirón de Robles.   

Abstract

CONTEXT: Fasciola hepatica is known to cause bile duct inflammation and biliary obstruction but is rarely reported as responsible for producing acute pancreatitis. CASE REPORT: We report on a patient complaining of acute pancreatitis. Endoscopic retrograde cholangio-pancreatography showed distinct features and sphincterotomy allowed extraction of multiple parasites.
CONCLUSIONS: Pancreatitis may occur in some patients with fascioliasis, but the condition may be overlooked in chronic cases. Endoscopic retrograde cholangio-pancreatography rule out other possible causes of irregularity and thickening of the common bile duct wall. Parasite removal during endoscopic retrograde cholangio-pancreatography is one therapeutic option. Hepatic involvement must be ruled out and complete pharmacological treatment is advised in this patient.

Entities:  

Mesh:

Year:  2005        PMID: 15650283

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

1.  Clinical presentation and management of Fasciola hepatica infection: single-center experience.

Authors:  Muhsin Kaya; Remzi Beştaş; Sedat Cetin
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

2.  Cholangiocarcinoma in magnetic resonance cholangiopancreatography and fascioliasis in endoscopic ultrasonography.

Authors:  Amir Houshang Mohammad Alizadeh; Mohammad Roshani; Farhad Lahmi; Nasrin Ahangar Davoodi; Mohammad Rostami Nejad; Mohammad Reza Seyyedmajidi; Mohammad Reza Zali
Journal:  Case Rep Gastroenterol       Date:  2011-10-01

3.  Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse.

Authors:  Jasmina Saric; Jia V Li; Yulan Wang; Jennifer Keiser; Kirill Veselkov; Stephan Dirnhofer; Ivan K S Yap; Jeremy K Nicholson; Elaine Holmes; Jürg Utzinger
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.